BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Chubb
Novartis
McKinsey
Argus Health
Fish and Richardson
Cantor Fitzgerald
McKesson
Dow
Colorcon

Generated: January 20, 2018

DrugPatentWatch Database Preview

METHAZOLAMIDE Drug Profile

« Back to Dashboard

When do Methazolamide patents expire, and what generic alternatives are available?

Methazolamide is a drug marketed by Ani Pharms Inc, Applied Anal, Mikart, and Sandoz. and is included in five NDAs.

The generic ingredient in METHAZOLAMIDE is methazolamide. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
Drug patent expirations by year for METHAZOLAMIDE
Medical Subject Heading (MeSH) Categories for METHAZOLAMIDE

US Patents and Regulatory Information for METHAZOLAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc METHAZOLAMIDE methazolamide TABLET;ORAL 040001-001 Jun 30, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040036-001 Jun 30, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applied Anal METHAZOLAMIDE methazolamide TABLET;ORAL 040011-002 Jul 17, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040102-001 Aug 28, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc METHAZOLAMIDE methazolamide TABLET;ORAL 040001-002 Jun 30, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applied Anal METHAZOLAMIDE methazolamide TABLET;ORAL 040011-001 Jul 17, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mikart METHAZOLAMIDE methazolamide TABLET;ORAL 040062-002 Jan 27, 1994 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mikart METHAZOLAMIDE methazolamide TABLET;ORAL 040062-001 Jan 27, 1994 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040102-002 Aug 28, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz METHAZOLAMIDE methazolamide TABLET;ORAL 040036-002 Jun 30, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Chinese Patent Office
US Army
McKesson
Baxter
AstraZeneca
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot